• By Vivien Williams

Mayo Clinic Minute: Drug Combo for Lung Cancer

March 24, 2016

three doctors pointing and viewing a computer monitor in a cancer research labLung cancer is the leading cause of cancer deaths in the U.S. But, lung cancer is not one size fits all. There are variations in the disease that make some cases harder to treat than others. In a laboratory setting, Mayo Clinic researchers have found that a combination of a drug used to treat rheumatoid arthritis and an experimental agent shut down a common and aggressive type of lung cancer.

In this Mayo Clinic Minute, reporter Vivien Williams talks to Dr. Alan Fields about the new drug combo and what it may mean for patients.

Watch the Mayo Clinic Minute.

Journalists: Broadcast-quality video is in the downloads. Read the script.